Suscribirse

Role of per-oral pancreatoscopy in the evaluation of suspected pancreatic duct neoplasia: a 13-year U.S. single-center experience - 20/04/17

Doi : 10.1016/j.gie.2016.07.040 
Ihab I. El Hajj, MD, MPH 1, 2, Brian C. Brauer, MD 1, Sachin Wani, MD 1, Norio Fukami, MD 1, 3, Augustin R. Attwell, MD 1, Raj J. Shah, MD 1,
1 Division of Gastroenterology, Department of Medicine, University of Colorado Anschutz Medical Campus, Denver, Colorado, USA 
2 Division of Gastroenterology, Department of Medicine, Indiana University, Indianapolis, Indiana, USA 
3 Division of Gastroenterology, Department of Medicine, Mayo Clinic, Scottsdale, Arizona, USA 

Reprint requests: Raj J. Shah, MD, FACG, Professor of Medicine, Director, Pancreaticobiliary Endoscopy, Division of Gastroenterology and Hepatology, University of Colorado Denver, 1635 Aurora Court, MS F735, Rm AIP 2.031, Aurora, CO 80045.Professor of MedicineDirectorPancreaticobiliary EndoscopyDivision of Gastroenterology and HepatologyUniversity of Colorado Denver1635 Aurora Court, MS F735, Rm AIP 2.031AuroraCO 80045

Abstract

Background and Aims

The role of per-oral pancreatoscopy (POP) in the evaluation of occult pancreatic duct (PD) lesions remains limited to case series. The aim of this study was to evaluate the ability of POP to differentiate malignant from benign diseases of the PD.

Methods

Patients who underwent POP between 2000 and 2013 for the evaluation of indeterminate PD strictures, dilatations, or with suspected or known main duct intraductal papillary mucinous neoplasm were identified. Main outcome measurements were visual impression accuracy, POP tissue sampling, efficacy, and safety of POP.

Results

During the study period, 79 patients who underwent POP for the evaluation of pancreatic stricture or dilatation were identified. Technical success was achieved in 78 (97%). In the PD neoplasia group (n = 33), the final diagnosis was based on index confirmatory POP-guided tissue sampling in 29 (88%). For the detection of PD neoplasia, POP visual impression had a sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of 87%, 86%, 83%, 91%, and 87%, respectively. When combined with POP-guided tissue sampling, the values were 91%, 95%, 94%, 93%, and 94%, respectively. Of 102 POPs performed, adverse events were noted in 12 (12%) cases.

Conclusions

This study demonstrates a high technical success rate, visual impression accuracy, and tissue sampling capability of POP. Examinations were performed by endoscopists with expertise in pancreatoscopy interpretation, and the results may not be generalizable.

El texto completo de este artículo está disponible en PDF.

Abbreviations : BD, FN, FP, IPMN, MD, NPV, PAB, PD, PDB, POP, PPV


Esquema


 DISCLOSURE: Dr. Shah has received consultancy fees from Boston Scientific and Cook Medical. Dr. Brauer has received consultancy fees from Boston Scientific. All other authors disclosed no financial relationships relevant to this publication.
 If you would like to chat with an author of this article, you may contact Dr. Shah at raj.shah@ucdenver.edu.


© 2017  American Society for Gastrointestinal Endoscopy. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 85 - N° 4

P. 737-745 - avril 2017 Regresar al número
Artículo precedente Artículo precedente
  • One-dimensional and 2-dimensional tumor size measurement for prediction of lymph node metastasis in differentiated early gastric cancer with minute submucosal invasion
  • Tae Jun Kim, Hyuk Lee, Yang Won Min, Byung-Hoon Min, Jun Haeng Lee, Kyoung-Mee Kim, Min-Ji Kim, Kyunga Kim, Poong-Lyul Rhee, Jae J. Kim
| Artículo siguiente Artículo siguiente
  • A prospective multicenter study of submucosal injection to improve endoscopic snare papillectomy for ampullary adenoma
  • Jong Jin Hyun, Tae Hoon Lee, Jin-Seok Park, Joung-Ho Han, Seok Jeong, Seon Mee Park, Hong Sik Lee, Jong Ho Moon, Sang-Heum Park

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2024 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.